BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 21943944)

  • 21. Nasal biomarker profiles in acute and chronic rhinosinusitis.
    Riechelmann H; Deutschle T; Rozsasi A; Keck T; Polzehl D; Bürner H
    Clin Exp Allergy; 2005 Sep; 35(9):1186-91. PubMed ID: 16164446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. TGF-β1 Induces Epithelial-Mesenchymal Transition of Chronic Sinusitis with Nasal Polyps through MicroRNA-21.
    Li X; Li C; Zhu G; Yuan W; Xiao ZA
    Int Arch Allergy Immunol; 2019; 179(4):304-319. PubMed ID: 30982052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
    Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced expression of antimicrobial PLUNC proteins in nasal polyp tissues of patients with chronic rhinosinusitis.
    Seshadri S; Lin DC; Rosati M; Carter RG; Norton JE; Suh L; Kato A; Chandra RK; Harris KE; Chu HW; Peters AT; Tan BK; Conley DB; Grammer LC; Kern RC; Schleimer RP
    Allergy; 2012 Jul; 67(7):920-8. PubMed ID: 22676062
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for altered levels of IgD in the nasal airway mucosa of patients with chronic rhinosinusitis.
    Min JY; Nayak JV; Hulse KE; Stevens WW; Raju PA; Huang JH; Suh LA; Van Roey GA; Norton JE; Carter RG; Price CPE; Weibman AR; Rashan AR; Ghosn EE; Patel ZM; Homma T; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Kato A; Hwang PH; Kern RC; Herzenberg LA; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Dec; 140(6):1562-1571.e5. PubMed ID: 28625807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The antimicrobial protein short palate, lung, and nasal epithelium clone 1 (SPLUNC1) is differentially modulated in eosinophilic and noneosinophilic chronic rhinosinusitis with nasal polyps.
    Wei Y; Xia W; Ye X; Fan Y; Shi J; Wen W; Yang P; Li H;
    J Allergy Clin Immunol; 2014 Feb; 133(2):420-8. PubMed ID: 24342548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of lipopolysaccharide on glucocorticoid receptor function in control nasal mucosa fibroblasts and in fibroblasts from patients with chronic rhinosinusitis with nasal polyps and asthma.
    Fernández-Bertolín L; Mullol J; Fuentes-Prado M; Roca-Ferrer J; Alobid I; Picado C; Pujols L
    PLoS One; 2015; 10(5):e0125443. PubMed ID: 25943109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of high mobility group box chromosomal protein 1 in eosinophilic chronic rhinosinusitis with nasal polyps.
    Chen D; Mao M; Bellussi LM; Passali D; Chen L
    Int Forum Allergy Rhinol; 2014 Jun; 4(6):453-62. PubMed ID: 24504744
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
    Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
    J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcription factors gene expression in chronic rhinosinusitis with and without nasal polyps.
    Soklic TK; Rijavec M; Silar M; Koren A; Kern I; Hocevar-Boltezar I; Korosec P
    Radiol Oncol; 2019 Jul; 53(3):323-330. PubMed ID: 31326962
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological profiling in chronic rhinosinusitis with nasal polyps reveals distinct VEGF and GM-CSF signatures during symptomatic exacerbations.
    Divekar RD; Samant S; Rank MA; Hagan J; Lal D; O'Brien EK; Kita H
    Clin Exp Allergy; 2015 Apr; 45(4):767-78. PubMed ID: 25429844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Naive and effector B-cell subtypes are increased in chronic rhinosinusitis with polyps.
    Miljkovic D; Psaltis A; Wormald PJ; Vreugde S
    Am J Rhinol Allergy; 2018 Jan; 32(1):3-6. PubMed ID: 29336281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The oxidant-antioxidant imbalance was involved in the pathogenesis of chronic rhinosinusitis with nasal polyps.
    Zhou J; Zhou J; Liu R; Liu Y; Meng J; Wen Q; Luo Y; Liu S; Li H; Ba L; Du J
    Front Immunol; 2024; 15():1380846. PubMed ID: 38756779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased thrombin-activatable fibrinolysis inhibitor levels in patients with chronic rhinosinusitis with nasal polyps.
    Imoto Y; Kato A; Takabayashi T; Stevens W; Norton JE; Suh LA; Carter RG; Weibman AR; Hulse KE; Harris KE; Peters AT; Grammer LC; Tan BK; Welch K; Shintani-Smith S; Conley DB; Kern RC; Fujieda S; Schleimer RP
    J Allergy Clin Immunol; 2019 Dec; 144(6):1566-1574.e6. PubMed ID: 31562871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nasal interleukin 25 as a novel biomarker for patients with chronic rhinosinusitis with nasal polyps and airway hypersensitiveness: A pilot study.
    Chen F; Hong H; Sun Y; Hu X; Zhang J; Xu G; Zhao W; Li H; Shi J
    Ann Allergy Asthma Immunol; 2017 Oct; 119(4):310-316.e2. PubMed ID: 28870448
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of YKL40 in the pathogenesis of CRS with nasal polyps.
    Ma Y; Zheng C; Shi L
    Eur Arch Otorhinolaryngol; 2018 Feb; 275(2):431-438. PubMed ID: 29299744
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of interleukin-33 in chronic rhinosinusitis.
    Kim DK; Jin HR; Eun KM; Mo JH; Cho SH; Oh S; Cho D; Kim DW
    Thorax; 2017 Jul; 72(7):635-645. PubMed ID: 27885166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IL-22/IL-22R1 signaling regulates the pathophysiology of chronic rhinosinusitis with nasal polyps via alteration of MUC1 expression.
    Noyama Y; Okano M; Fujiwara T; Kariya S; Higaki T; Haruna T; Makihara SI; Kanai K; Koyama T; Taniguchi M; Ishitoya JI; Kanda A; Kobayashi Y; Asako M; Tomoda K; Nishizaki K
    Allergol Int; 2017 Jan; 66(1):42-51. PubMed ID: 27502468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps.
    Tan BK; Li QZ; Suh L; Kato A; Conley DB; Chandra RK; Zhou J; Norton J; Carter R; Hinchcliff M; Harris K; Peters A; Grammer LC; Kern RC; Mohan C; Schleimer RP
    J Allergy Clin Immunol; 2011 Dec; 128(6):1198-1206.e1. PubMed ID: 21996343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IgD-activated mast cells induce IgE synthesis in B cells in nasal polyps.
    Zhai GT; Wang H; Li JX; Cao PP; Jiang WX; Song J; Yao Y; Wang ZC; Wang ZZ; Wang MC; Liao B; Feng QM; Lu X; Wang H; Gao P; Liu Z
    J Allergy Clin Immunol; 2018 Nov; 142(5):1489-1499.e23. PubMed ID: 30102935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.